Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 768

1.

Challenges and Achievements in Prevention and Treatment of Smallpox.

Melamed S, Israely T, Paran N.

Vaccines (Basel). 2018 Jan 29;6(1). pii: E8. doi: 10.3390/vaccines6010008. Review.

2.

E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.

Volz A, Jany S, Freudenstein A, Lantermann M, Ludwig H, Sutter G.

Viruses. 2018 Jan 4;10(1). pii: E21. doi: 10.3390/v10010021.

3.

Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant.

Reeman S, Gates AJ, Pulford DJ, Krieg A, Ulaeto DO.

Viruses. 2017 Dec 9;9(12). pii: E378. doi: 10.3390/v9120378.

4.

Vaccinia Virus Natural Infections in Brazil: The Good, the Bad, and the Ugly.

Oliveira JS, Figueiredo PO, Costa GB, Assis FL, Drumond BP, da Fonseca FG, Nogueira ML, Kroon EG, Trindade GS.

Viruses. 2017 Nov 15;9(11). pii: E340. doi: 10.3390/v9110340. Review.

5.

Equination (inoculation of horsepox): An early alternative to vaccination (inoculation of cowpox) and the potential role of horsepox virus in the origin of the smallpox vaccine.

Esparza J, Schrick L, Damaso CR, Nitsche A.

Vaccine. 2017 Dec 19;35(52):7222-7230. doi: 10.1016/j.vaccine.2017.11.003. Epub 2017 Nov 11. Review.

6.

Comparing New-Generation Candidate Vaccines against Human Orthopoxvirus Infections.

Maksyutov RA, Yakubitskyi SN, Kolosova IV, Shchelkunov SN.

Acta Naturae. 2017 Apr-Jun;9(2):88-93.

7.

Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.

Kumar J, Yadav VN, Phulera S, Kamble A, Gautam AK, Panwar HS, Sahu A.

J Virol. 2017 Sep 12;91(19). pii: e00668-17. doi: 10.1128/JVI.00668-17. Print 2017 Oct 1.

PMID:
28724763
8.

Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology.

Eldi P, Cooper TH, Liu L, Prow NA, Diener KR, Howley PM, Suhrbier A, Hayball JD.

Mol Ther. 2017 Oct 4;25(10):2332-2344. doi: 10.1016/j.ymthe.2017.06.017. Epub 2017 Jul 15.

9.

Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.

Martínez O, Bravo Cruz A, Santos S, Ramírez M, Miranda E, Shisler J, Otero M.

Vaccine. 2017 Oct 20;35(44):6007-6014. doi: 10.1016/j.vaccine.2017.05.091. Epub 2017 Jun 16.

10.

Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models.

Achdout H, Lustig S, Israely T, Erez N, Politi B, Tamir H, Israeli O, Waner T, Melamed S, Paran N.

Vaccine. 2017 Jul 24;35(33):4245-4254. doi: 10.1016/j.vaccine.2017.06.014. Epub 2017 Jun 20.

PMID:
28625523
11.

Comparative Efficacy of Intramuscular and Scarification Routes of Administration of Live Smallpox Vaccine in a Murine Challenge Model.

Phelps A, Gates AJ, Eastaugh L, Hillier M, Ulaeto DO.

Vaccine. 2017 Jul 5;35(31):3889-3896. doi: 10.1016/j.vaccine.2017.05.058. Epub 2017 Jun 9.

PMID:
28606813
12.

Duration of neutralizing antibody persisting in Thai individuals after childhood vaccination against smallpox.

Kwanchum K, Ampol S, Thongput A, Horthongkham N, Udomphunthurak S, Siritantikorn S, Kantakamalakul W.

Asian Pac J Allergy Immunol. 2017 Dec;35(4):239-243. doi: 10.12932/AP0857.

13.

Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine Vector.

Pavot V, Sebastian S, Turner AV, Matthews J, Gilbert SC.

Methods Mol Biol. 2017;1581:97-119. doi: 10.1007/978-1-4939-6869-5_6.

PMID:
28374245
14.

Vaccinia virus evasion of regulated cell death.

Veyer DL, Carrara G, Maluquer de Motes C, Smith GL.

Immunol Lett. 2017 Jun;186:68-80. doi: 10.1016/j.imlet.2017.03.015. Epub 2017 Mar 31. Review.

15.

Antibody Recognition of Immunodominant Vaccinia Virus Envelope Proteins.

Zajonc DM.

Subcell Biochem. 2017;83:103-126. doi: 10.1007/978-3-319-46503-6_4.

PMID:
28271474
16.

Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial.

Jackson LA, Frey SE, El Sahly HM, Mulligan MJ, Winokur PL, Kotloff KL, Campbell JD, Atmar RL, Graham I, Anderson EJ, Anderson EL, Patel SM, Fields C, Keitel W, Rouphael N, Hill H, Goll JB.

Vaccine. 2017 Mar 23;35(13):1675-1682. doi: 10.1016/j.vaccine.2017.02.032. Epub 2017 Feb 27.

PMID:
28256358
17.

Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.

Volz A, Sutter G.

Adv Virus Res. 2017;97:187-243. doi: 10.1016/bs.aivir.2016.07.001. Epub 2016 Aug 1. Review.

PMID:
28057259
18.

Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations.

Slike BM, Creegan M, Marovich M, Ngauy V.

PLoS One. 2017 Jan 3;12(1):e0169247. doi: 10.1371/journal.pone.0169247. eCollection 2017.

19.

A Single Vaccination of Nonhuman Primates with Highly Attenuated Smallpox Vaccine, LC16m8, Provides Long-term Protection against Monkeypox.

Iizuka I, Ami Y, Suzaki Y, Nagata N, Fukushi S, Ogata M, Morikawa S, Hasegawa H, Mizuguchi M, Kurane I, Saijo M.

Jpn J Infect Dis. 2017 Jul 24;70(4):408-415. doi: 10.7883/yoken.JJID.2016.417. Epub 2016 Dec 22.

20.

17<sup>th</sup> Century Variola Virus Reveals the Recent History of Smallpox.

Duggan AT, Perdomo MF, Piombino-Mascali D, Marciniak S, Poinar D, Emery MV, Buchmann JP, Duchêne S, Jankauskas R, Humphreys M, Golding GB, Southon J, Devault A, Rouillard JM, Sahl JW, Dutour O, Hedman K, Sajantila A, Smith GL, Holmes EC, Poinar HN.

Curr Biol. 2016 Dec 19;26(24):3407-3412. doi: 10.1016/j.cub.2016.10.061. Epub 2016 Dec 8.

Supplemental Content

Loading ...
Support Center